COVID-19, Influenza A/B, Seasonal Influenza A subtyping, Influenza A/H5 and Influenza A/H7 Extraction Reagents
Closed Special Notice Posted
- Solicitation number
- 1301337914
- Agency
-
Naval Supply Systems Command
Department of the Navy, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Place of performance
- Maryland 20910, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Naval Medical Research Command (NMRC), operating under the Department of the Navy Naval Supply Systems Command, issued a Special Notice on March 3, 2026, announcing its intent to award a sole-source contract to Roche Diagnostics Corporation for diagnostic extraction reagents. The notice seeks to procure supplies for the Naval Infectious Diseases Diagnostic Laboratory to support COVID-19, Influenza A/B, Seasonal Influenza A subtyping, Influenza A/H5, and Influenza A/H7 testing capabilities. Although the government intends to award this contract to Roche Diagnostics without competitive bidding, interested vendors may submit capability statements for government consideration. The procurement falls under FAR Part 12 Commercial Items guidelines and is classified under NAICS code 325413 (In-Vitro Diagnostic Substance Manufacturing). This is a brand-specific requirement due to the specialized diagnostic-grade nature of the reagents needed.
The requirement calls for 4,000 total extraction reactions to be delivered in four bi-monthly shipments scheduled for June 2026, September 2026, December 2026, and March 2027, with each shipment containing 1,000 reactions worth of specific Roche MagNA Pure products. The total contract value is $31,654.00 funded through Navy Fiscal Year 2026 appropriations, and the solicitation deadline for capability statements is March 17, 2026. All contractors must register with the Systems for Award Management (SAM) and obtain a Unique Entity Identification Number (UEI) to be eligible for award consideration. The government will conduct a price analysis to ensure fair and reasonable pricing and anticipates negotiating a discount from Roche's commercial price list. Interested parties should direct inquiries to the Material Management Department at NMRC via email at usn.detrick.nmrc.mbx.mmd-contracts@health.mil.
Notice text
The United States Department of the Naval Medical Research Command (NMRC) intends to award a sole source contract to, Roche Diagnostics Corporation, Indianapolis, Indiana. This requirement is for brand name equipment. This notice is not a request for competitive proposals however If interested, please submit a capability statement for Government consideration.
NMRC's Naval Infectious Diseases Diagnostic Laboratory is in need for a drop shipment of Roche supplies needed for COVID-19, Influenza A/B, Seasonal Influenza A subtyping, Influenza A/H5 and Influenza A/H7 extraction reagents. This requirement is for the purchase of reagents for 1,000 extraction reactions for the assays mentioned every three months for four complete shipments, for a total of 4,000 reactions.
Specific items include:
(1) MagNA Pure 96 Processing Cartridge (Cat. 06241603001)/QTY: 12;
(2) MagNA Pure Filter Tips (1000 ul) (Cat. 06241620001)/QTY: 2;
(3) MagNA Pure External Lysis Buffer (Cat. 06374913001)/QTY: 32;
(4) MagNA Pure 96 DNA and Viral NA SV Kit (Cat. 06543588001)/QTY: 8; and
(5) MagNA Pure 96 System Fluid (External) (Cat. 06640729001)/QTY: 12.
Please note that this requirement includes numerous shipments and the proposed shipping schedule is included below. There will be 4 separate bi-monthly shipments. Proposed ship schedule: Jun-2026, Sep-2026, Dec-2026, Mar-2027.
The NAICS code for this action is 325413. This requirement will be procured under the guidelines of FAR Part 12 Commercial Items. NMRC requires that all contractors doing business with the Contracts Office must be registered with the Systems for Award Management (SAM). No award can be made unless the vendor is registered in Systems for Award Management. For additional information and to register in SAM, please access the following website: https://www.sam.gov/. In order to register with the SAM and to be eligible to receive an award from this Contracts Office, all offers must have a Unique Entity Identification Number (UEI). A Sam.gov number may be acquired by contacting Sam.gov online at www.sam.gov or by phone at (866) 606-8220.
Files
| File | Type | Posted |
|---|---|---|
| Shipment Schedule_Reagents.docx | DOCX document | |
| ERP PR 1301337914_JNA_Redacted.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Comprehensive full-service maintenance/repair plan for Illumina Nova/Seq 6000 | Naval Supply Systems Command | No set-aside | |
| Reagent powder | Naval Supply Systems Command | No set-aside | |
| Reagents and consumables for Roche immunostainers | Office of Logisitics and Acquisition Operations | No set-aside | |
| 6550--Cepheid GeneXpert Testing Supplies | Veterans Integrated Service Network 5 | No set-aside | |
| Purchase of Rapid Syndromic Molecular Testing Reagents for Seattle VAMC | Veterans Integrated Service Network 20 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity